Bioniq has raised £11.5 million in Series B funding for its personalised supplements based on blood biomarker data. Founded in 2019, the London firm will use the funds to further expand its global market share. It will focus on global laboratory network integrations; market, operational and human resources expansion in the US and the Middle … Continue reading Bioniq, used by Manchester United & NBA stars, raises Series B round